Polydex Pharmaceuticals Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.07 |
Market Cap |
$3.72 M |
Shares Outstanding |
3.38 M |
Public Float |
- |
Address |
421 Comstock Road Toronto Ontario M1L 2H5 Canada |
Employees | - |
Website | http://www.polydex.com |
Updated | 07/08/2019 |
Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. If focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. |